At the time of writing, DENTSPLY Sirona Inc [XRAY] stock is trading at $19.05, up 1.60%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The XRAY shares have gain 3.98% over the last week, with a monthly amount drifted -2.01%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
DENTSPLY Sirona Inc [NASDAQ: XRAY] stock has seen the most recent analyst activity on February 14, 2025, when Wells Fargo initiated its Equal Weight rating and assigned the stock a price target of $20. Previously, Jefferies downgraded its rating to Hold on January 23, 2025, and dropped its price target to $20. On January 07, 2025, downgrade downgraded it’s rating to In-line but maintained its price target of $20 on the stock. Mizuho started tracking the stock assigning a Neutral rating and suggested a price target of $21 on December 04, 2024. Leerink Partners downgraded its rating to a Market Perform. Needham reiterated a Buy rating for this stock on October 25, 2024, and downed its price target to $29. In a note dated August 20, 2024, Needham reiterated an Buy rating on this stock but restated the target price of $34.
For the past year, the stock price of DENTSPLY Sirona Inc fluctuated between $17.21 and $34.91. Currently, Wall Street analysts expect the stock to reach $20 within the next 12 months. DENTSPLY Sirona Inc [NASDAQ: XRAY] shares were valued at $19.05 at the most recent close of the market. An investor can expect a potential return of 4.99% based on the average XRAY price forecast.
Analyzing the XRAY fundamentals
According to DENTSPLY Sirona Inc [NASDAQ:XRAY], the company’s sales were 3.90B for trailing twelve months, which represents an 0.42% jump. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.06, Equity is -0.14 and Total Capital is -0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.93.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 18.69 points at the first support level, and at 18.33 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.25, and for the 2nd resistance point, it is at 19.46.
Ratios To Look Out For
It is important to note that DENTSPLY Sirona Inc [NASDAQ:XRAY] has a current ratio of 1.25. In addition, the Quick Ratio stands at 0.84 and the Cash Ratio stands at 0.19. Considering the valuation of this stock, the price to sales ratio is 0.97, the price to book ratio is 1.52.
Transactions by insiders
Recent insider trading involved Coleman Glenn, Former Officer, that happened on Jan 27 ’25 when 15759.0 shares were purchased. Director, LUCIER GREGORY T completed a deal on Nov 18 ’24 to buy 5000.0 shares. Meanwhile, Director LUCIER GREGORY T bought 1000.0 shares on Nov 15 ’24.
